Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03046550 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
A Phase 1 study, sponsored by Alachua Government Services.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT03046550 is a Phase 1 study that has completed, run by Alachua Government Services. The registered enrollment target is 25 participants.
The verdict
NCT03046550, a Phase 1 study, has completed, sponsored by Alachua Government Services.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study evaluates the safety and pharmacokinetics of NTM-1634 in healthy subjects.
Interventions
- DRUG Placebo
- DRUG NTM-1634
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2017-10-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03046550
The ClinicalTrials.gov registry entry for NCT03046550 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alachua Government Services, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03046550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03046550 about?
NCT03046550 is a clinical study titled "Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults". This study evaluates the safety and pharmacokinetics of NTM-1634 in healthy subjects.
What is the current status of trial NCT03046550?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2017-03-20. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT03046550?
The interventions under investigation include: Placebo (DRUG), NTM-1634 (DRUG).
Who is sponsoring clinical trial NCT03046550?
This trial is sponsored by Alachua Government Services, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.